Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Budigalimab + ABBV-382 for HIV/AIDS
Recruiting0 awardsPhase 2
Albuquerque, New Mexico
This trial is testing investigational drugs for the treatment of HIV. 140 people with HIV will receive 4 doses of IV budigalimab or placebo and 3 doses of IV ABBV-382 or placebo for 8 weeks. They will be monitored for up to 52 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.